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Complex metabolism is thought to occur exclusively in the crowded intracellular environment. Here we
report that diluted enzymes from lysed human leukocytes produce extracellular energy. Our ﬁndings
involve two pathways: the purine nucleotide catabolic pathway and the pentose phosphate pathway,
which function together to generate energy as NADPH. Glucose6P fuel for NADPH production is gener-
ated from structural ribose of purine ribonucleoside monophosphates, ADP, and ADP-ribose. NADPH
drives glutathione reductase to reduce an oxidized glutathione disulﬁde-glutathione redox couple. Acid
phosphatases initiate ribose5P salvage from purine ribonucleoside monophosphates, and transaldolase
controls the direction of carbon chain ﬂow through the nonoxidative branch of the pentose phosphate
pathway. These metabolic control points are regulated by pH. Biologically, this energy conserving me-
tabolism could function in perturbed extracellular spaces.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The impetus for the experiments reported here occurred while
studying the synthesis of nitric oxide (NO) from L-arginine by
murine NO synthase in 100,000g supernatants. This reaction is
driven by reducing equivalents delivered by NADPH [1]. However,
in control experiments, we observed that purine ribonucleotides,
which do not carry energy as reducing equivalents, could sub-
stitute for NADPH and drive the NO synthase reaction. This result,
at that time, did not have a rational explanation. Later, in an at-
tempt to understand this puzzling observation, we used cytosolB.V. This is an open access article u
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s Jr.).prepared from human leukocytes to detect NADPH production.
Cytosol, a term often inaccurately employed to describe the
aqueous cytoplasm of intact cells, is referred to here as: “that
portion of the cell which is found in the supernatant fraction after
centrifuging the homogenate, diluted in buffer, at 105,000g for
1 h” [2]. The concentration of cytosolic proteins in experimental
reaction mixtures ranged from 75 ng/μl to 200 ng/μl (0.0075% to
0.02% protein solution respectively). This represents cytosolic
proteins obtained from 3.38103 to 9103 leukocytes which, in
cells/μl, correspond to a low to normal adult human peripheral
blood leukocyte count [3] based on a calculation of 22.2 pg of
cytosolic protein/leukocyte (see Section 2).
Cytosolic proteins contain enzymes that normally function in
the crowded aqueous cytoplasm of intact cells (170103 ng/μl to
350103 ng/μl protein) [4]. However, after release from human
leukocytes and dilution to 75 ng/μl to 200 ng/μl protein, the di-
luted enzymes generate energy as NADPH that counters oxidative
challenge in the form of added GSSG via cytosolic glutathione
reductase [5] (Fig. 1, Reaction 14). Coordinated metabolism by
released enzymes survives leukocyte homogenization, cytosol
preparation and dilution of cytosolic proteins.
Using this experimental system, we observed that ribose5P, ander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Metabolism and NADPH production in dilute cytosol prepared from human
leukocytes as measured by reduction of added GSSG to 2GSH by cytosolic glu-
tathione reductase (Reaction 14). Other cytosolic enzymes involved in this energy
yielding extracellular metabolism are: 1. adenylate kinase, 2. cytosolic acid phos-
phatases, 3. adenosine deaminase, 4. purine nucleoside phosphorylase 5. phos-
phoribomutase, 6. ribulose5P isomerase, 7. ribulose5P epimerase, 8. transketolase,
9. transaldolase, 10. phosphoglucose isomerase, 11. glucose6P dehydrogenase, 12.
6-phosphogluconolactonase, 13. 6-phosphogluconate dehydrogenase, and 15. ADP-
ribose pyrophosphatase. Blue coded reactions are inhibited by NaF, and red coded
reactions are inhibited by pH 7.9–8.2. (For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the web version of this article.)
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sphates, ADP, and ADP-ribose (produced in stressed cells) [6], is
salvaged and metabolically converted to glucose6P. Glucose6P is
the immediate carbon chain fuel for NADPH production. In effect,
this dilute solution metabolism, which generates reducing
equivalents carried by NADPH from molecules containing a ribo-
se5P moiety, acts as an extracellular biofuel cell. It is an extra-
cellular energy conserving process that occurs without energy
input or a need for oxygen. See Fig. 1 for a summary of the ex-
tracellular metabolism discussed.
The enzymatically catalyzed dilute solution sugar phosphatate
interconversion reactions reported here are similar to the enzyme
free abiotic dilute solution metabolism recently reported to sup-
port the theory of a prebiotic origin of metabolism (see Section 4).2. Materials and methods
2.1. Biochemical reagents
3-(N-Morpholino)propanesulfonic acid, 4-Morpholinepropa-
nesulfonic acid (MOPS), 5,5′-Dithiobis(2-nitrobenzoic acid (DTNB),
Adenosine 5′-diphosphoribose sodium salt (ADP-ribose), Dextran
from Leuconostoc mesenteroides, D-Glucose 6-phosphate dis-
odium salt hydrate, D-Ribose 5-phosphate disodium salt hydrate, L-
Ascorbic acid, L-Glutathione oxidized disodium salt (GSSG), N-[Tris
(hydroxymethyl)methyl]glycine (Tricine), Penicillin G potassium
salt, Potassium phosphate monobasic anhydrous (KH2PO4), β-Ni-
cotinamide adenine dinucleotide 2′-phosphate reduced tetra-
sodium salt hydrate (NADPH), β-Nicotinamide adenine dinucleo-
tide phosphate sodium salt hydrate (NADPþ), Adenosine 3′-
monophosphate (AMP-3′), Adenosine 5′-monophosphate sodium
salt (AMP-5′), Adenosine 5′-diphosphate sodium salt (ADP), Ade-
nosine 5′-triphosphate disodium salt (ATP), Ammonium mo-
lybdate tetrahydrate, Ethylenediaminetetraacetic acid disodium
salt dihydrate (EDTA), Guanosine 5′-monophosphate disodium salt
hydrate (GMP), Inosine, Inosine 5’-monophosphate disodium salt
(IMP), L-Glutathione reduced (GSH), N,N-Bis(2-hydroxyethyl)gly-
cine (Bicine), Phenol red solution 0.5%, Sodium chloride, Sodium
ﬂuoride (NaF), Sodium phosphate dibasic (Na2HPO4), Sodium
phosphate monobasic monohydrate (NaH2PO4 H2O), were from
Sigma-Aldrich, St Louis, MO, USA. Heparin, sodium solution and N-
[2-Hydroxyethyl]piperazine-N′-[2-Ethanesulfonic Acid] (HEPES)
were from USB, Cleveland, OH, USA. Human prostate acid phos-
phatase was from Lee Biosolutions Inc., St Louis, MO, USA. Sulfuric
acid was from Mallinckrodt Baker, St Louis, MO, USA.
2.2. Source of human leukocytes and human serum
Three healthy male donors ranging in age from 28–75 y.o.
provided the peripheral blood leukocytes and the serum used in
these experiments. The University of Utah Health Science Center
and the Salt Lake City VA Medical Center Institutional Review
Boards approved this research. Written informed consent was
obtained from each of the participants.
2.3. Isolation of human leukocytes
Human venous blood (180–200 ml total) was collected asepti-
cally into four 50 ml syringes containing heparin at a ﬁnal con-
centration of 20 units/ml. The heparinized blood was mixed with
an equal volume of 0.9% NaCl solution containing 2% Dextran
(MW¼400,000–500,000 from Sigma Cat. no. D103) and held at
room temperature for 40 min to permit sedimentation of ery-
throcytes. The leukocyte rich supernatant was transferred to 50 ml
tubes and centrifuged 5 min at 700g to sediment leukocytes. The
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sterile distilled deionized water to the cell pellet for 20 s, followed
immediately by the addition of 45 ml 0.9% NaCl. The leukocytes
were washed three more times in 0.9% NaCl by centrifugation at
200g for 5 min. Total number of cells was determined by micro-
scopy using a hemocytometer.
2.4. Preparation of the 100,000g supernatant (cytosol) from human
peripheral blood leukocytes
Pelleted cells were re-suspended in a buffer containing
H2Oþ15 mM HEPESþphenol red 8 mg/L, pH 7.4 at 108 cells/ml
and disrupted by sonication (Bronson ultrasonic homogenizer).
Cell lysis was monitored by light microscopy and the process
stopped when 499% of the cells were disrupted. Two other
methods of cell disruption were used with identical results (a cell
disrupter bomb and a Potter-Elvehjem tissue grinder). The buffer
containing the disrupted cells was centrifuged at 100,000g at 4°
for 60 min (Beckman L5-5B centrifuge, SW 41 rotor). The 100,000g
supernatant was ﬁltered through a 0.22 mm ﬁlter, aliquoted, and
the protein concentration determined using the Bio-Rad Protein
Assay (Bio-Rad Laboratories, Inc. Catalog no. 500-0006). The ali-
quoted 100,000g supernatant protein was frozen at 70° until
used. Cytosol remains metabolically active for more than 1 year
after preparation when frozen at 70°. Proteinase inhibitors were
not added to cell lysates or to cytosol during preparation, storage,
or the bioassay. We deﬁne the 100,000g supernatant prepared
from lysates of human peripheral blood leukocytes as cytosol. The
term cytosol was ﬁrst proposed in 1965 by H.A. Lardy. His deﬁ-
nition is quoted by Clegg [2]. Cytosol approximates the aqueous
cytoplasm of intact cells.
We calculated the average contribution of cytosolic protein of
human peripheral blood leukocytes to be 22.2 pg/cell. Total cel-
lular protein of human peripheral blood neutrophils has been re-
ported to be 50 pg/cell [7]. The aqueous cytoplasm fraction has
been measured to be 57% of total human neutrophil cellular pro-
tein [8]. From these measurements, cytosolic protein is 28.5 pg
protein/human neutrophil. Lymphocytes are 20–45% of human
peripheral blood leukocytes [3]. Circulating lymphocytes are small
“resting” non-activated cells with scant aqueous cytoplasm. Our
measurement of 22.2 pg cytosolic protein/cell likely approximates
that of the heterogenous population of circulating human per-
ipheral blood leukocytes. Example of how we calculated average
cytosol protein contribution per leukocyte: 16.67 ml of a cytosolic
protein stock solution containing 0.6 mg of cytosolic protein/ml
was prepared from 450106 peripheral blood leukocytes
(16.67 ml0.6 mg/ml cytosolic protein¼10 mg total cytosolic
protein). 10 mg cytosolic protein¼10109 pg cytosolic
proteinC450106 leukocytes¼22.2 pg cytosolic protein/
leukocyte.
Human peripheral blood leukocytes should be used as the
source of cytosolic protein to reproduce the dilute solution ex-
tracellular metabolism reported here. Human DLD-1 colon ade-
nocarcinoma cells and murine EMT-6 mammary adenocarcinoma
cells require signiﬁcantly higher concentrations of cytosolic pro-
tein to carry out metabolism that is less efﬁcient (unpublished
data).
2.5. Collection and dialysis of human serum
Human serum was obtained by centrifugation (250g) of asep-
tically collected clotted blood and stored at 4° until use. 10 ml of
serum was placed into dialysis tubing (diameter 11.5 mm) with
molecular weight cut-off 3500 (Spectrum Laboratories Inc. Cat. no.
132720). The tubing was then immersed in 4 l of normal saline and
kept there with agitation for 24 h at 4°. After 24 h, the tubing wastransferred to 4 l of fresh normal saline. The process was repeated
one more time for total of three changes of dialysate. The serum
was removed and ﬁltered through 0.22 mm ﬁlter.
2.6. Basic assay for measurement of extracellular metabolism
Experiments were carried out in 96 well microtiter plates with
a ﬁnal volume (which included all additives and reagents) of 80 ml.
All reagents and additives used were dissolved in distilled deio-
nized water containing 15 mM HEPES and 8 mg/liter phenol red at
pH 7.4. The basic constituents of the 80 μl reaction mixtures were:
2 mM Mg(acetate)2, 50 mM NaCl, 100 units/ml penicillin G, and
8 mg/L phenol red. The choice of organic buffer used was based on
the pH poise desired for the experiment being performed: pH 6.9
(15 mM MOPS), pH 7.4 (15 mM HEPES), pH 7.9 (15 mM Tricine),
and pH 8.2 (15 mM Bicine). Reaction mixture pH was monitored
using an Orion Research Digital pH meter model 611. Concentra-
tions of cytosolic protein, GSSG (always 3 mM), the nicotinamide
nucleotide hydride ion carrier (NADPþ), and the carbon chain fuel
sources for each experiment are indicated in the Figure and/or in
the Figure legends of the experiments reported. The microtiter
plate was vortexed (to mix all reagents), sealed with pressure ﬁlm
(to prevent evaporation) and incubated for 20 h (unless otherwise
indicated) in the dark at 37°. At the end of incubation, aliquots of
reaction mixture were removed for measurement of reduced
glutathione, determination of inorganic phosphate and/or analysis
of metabolites via gas chromatography/mass spectrometry or li-
quid chromatography/mass spectrometry.
2.7. Reduced glutathione assay
We used a modiﬁcation of the enzymatic, kinetic glutathione
96 well microtiter plate assay described by Allen et. al. [9] to
measure GSH. Procedure for measurement of GSH: To prepare the
DTNB reagent add 1 ml of the DTNB stock solution to 14 ml of
phosphate buffered saline (PBS). Pipet 125 ml of the DTNB reagent
into a microtiter well. Add a 4 ml sample of experimental reaction
mixture to the DTNB reagent in a microtiter well and mix. Incubate
at room temperature for 5 min. Measure absorbance at 420 nm
using a TECAN GENios microplate reader with an appropriate
range of standards.
2.8. Inorganic phosphate assay
We used a modiﬁcation of the inorganic phosphate assay de-
scribed by Ames [10] which is based on the principle of phos-
phomolybdate complex reduction by ascorbic acid. This assay was
adapted for absorbance readings using small sample volumes from
experiments carried out in a microtiter plate. Procedure for mea-
surement of inorganic phosphate: Pipet 75 ml of the ascorbic acid/
molybdate reagent into a microtiter well. Add a 32 ml sample from
the experimental reaction mixture to the reagent in the microtiter
well, mix, and incubate for 1 h at 37°. Measure absorbance at
820 nm using a TECAN GENios microplate reader with an appro-
priate range of standards. Samples with higher phosphate levels
were diluted to measurable concentrations prior to assay.
2.9. Metabolite extraction and analysis by GC–MS and LC–MS
The method of Jiye et. al. [11] was used with slight modiﬁcation
to remove protein by precipitation. In brief, 684 μl of 20°, 90%
methanol (aq.) was added to 76 μl of the individual tubes con-
taining the assay to give a ﬁnal concentration of 80% methanol.
The samples were incubated for one hour at 20° followed by
centrifugation at 30,000g for 10 min using a rotor chilled to 20°.
The supernatant containing the extracted metabolites was then
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vacuo.
GC–MS analysis was performed on each metabolite present in
three replicate samples with a Waters GCT Premier mass spec-
trometer ﬁtted with an Agilent 6890 gas chromatograph and a
Gerstel MPS2 autosampler. Dried samples were suspended in 40 μl
of a 40 mg/ml O-methoxylamine hydrochloride (MOX) in pyridine
and incubated for one hour at 30°. 25 μl of this solution was added
to autosampler vials. 30 μl of N-methyl-N-trimethylsilyltri-
ﬂuoracetamide (MSTFA) was added automatically via the auto-
sampler and incubated for 60 min at 37° with shaking. After in-
cubation 3 μl of a fatty acid methyl ester standard solution was
added via the autosampler followed by 1 μl of the prepared
sample injected into the gas chromatograph inlet in the split mode
with the inlet temperature held at 250°. A 10:1 split ratio was used
for analysis. The gas chromatograph had an initial temperature of
95° for one minute followed by a 40°/min ramp to 110° and a hold
time of 2 min. This was followed by a second 5°/min ramp to 250°,
a third ramp to 350°, then a ﬁnal hold time of 3 min. A 30 m
Phenomex ZB5-5 MSi column with a 5 m long guard column was
employed for chromatographic separation. Heliumwas used as the
carrier gas at 1 mL/min. GC–MS data was collected using MassLynx
4.1 software (Waters). Metabolites were identiﬁed and their peak
area was recorded using QuanLynx (Waters). Metabolite identity
was established using chemical library developed using pure
purchased standards. These data were transferred to an Excel
spreadsheet. The total area for all metabolites observed in each
sample was summed, each metabolite was divided by this sum-
med total area and multiplied by 100 to produce percent meta-
bolite AUC.
LC–MS analysis was performed on each metabolite present in
three replicate samples as previously described [12]. In brief a
Phenomenex (Torrence, CA) 3.0 mm150 mm Gemini-NX C18
(5 μm) column with a Phenomenex Security Guard column ﬁlled
with the same packing material. The chromatographic system
consisted of an integrated Shimadzu HPLC system consisting of
two LC-10AD pumps, column oven and a CBM-20A controller. A
PE200 autosampler with a cooling unit set to 4° was used for
sample handling. A PE Sciex API 365 mass spectrometer modiﬁed
with an Ionics EP 10þ source was used for analyte detection. A
mobile phase consisting of solvent A (water with 15 mM ammo-
nium formate/6.5 mM N-dibutylamine) and solvent B (methanol/
6.5 mM N-dibutylamine) was used for elution of samples. The
initial condition was 5% B with an initial hold time of 3 min fol-
lowed by a ramp to 73% B over 21 min. A second ramp to 90% B
was employed over the next min with a 1 min hold. The column
was brought back to 5% B over two min and re-equilibrated for
9 min. The ﬂow rate was 0.3 mL/min at 24°. Mass spectrometer
transition optimization was performed using a syringe pump. For
each metabolite optimized it was dissolved in buffer A as a
1 mg/mL solution. Infusion was performed at 20 μl/min while 10%
B/90% A buffer was co-infused using the HPLC at 0.3 mL/min. To
each sample was added 50 μl of 10 mM K2PO4 pH 7 followed by a
brief sonication using a water bath sonicator. Each sample was
clariﬁed by 10 min of centrifugation at 20,000g followed by
transfer to an autosampler vial. Samples kept at 4° until analysis.
After analysis each metabolites peak height was recorded in Excel.
The total area for all metabolites observed in each sample was
summed, each metabolite was divided by this summed total area
and multiplied by 100 to produce percent metabolite AUC.
2.10. Statistical analysis
The data were analyzed using the biostatistical software
GraphPad Prisms 4.0. Graphical data models were created using
multiple grouping variables and standard two-way ANOVA tests.Analysis of variance was based on 3 or more replicates of each
tested variable, from which the Standard Error of the Mean (SEM)
and Standard Deviation (SD) were calculated.3. Results
3.1. Initiation of dilute solution extracellular energy conserving
metabolism
The ﬁrst enzymatic steps in extracellular NADPH generation is
the release of purine ribonucleoside monophosphate components
of larger molecules. Purine ribonucleoside monophosphates must
be salvaged from molecules such as RNA (not evaluated in this
study), ADP, and ADP-ribose. Purine ribonucleoside monopho-
sphates are stable molecules unless acted upon by acid phospha-
tases. The conversion of purine ribonucleoside monophosphates to
purine ribonucleosides by acid phophatases with 3′-5′ nucleoti-
dase activity is the enzymatic step that initiates extracellular dilute
solution metabolism. Purine ribonucleosides, once released, un-
dergo spontaneous catabolism that generates NADPH in dilute
cytosol.
To determine requirements for initiation of catabolism that
generates extracellular energy as NADPH, the reduction of added
GSSG to 2GSH by cytosolic glutathione reductase was measured.
We used NaF to inhibit the production of purine ribonucleosides
from larger molecules that are carbon chain fuel sources for
NADPH generation as determined by GSH production (Fig. 2A). NaF
inhibits lysosomal [13], prostate [14], and macrophage/osteoclast
[15] acid phosphatases. NaF also inhibits ADP-ribose pyropho-
sphatase [16] and prevents the generation of AMP-5′ and ribose5P
from ADP-ribose (Fig. 1, Reaction 15).
NaF decreased NADPH generation as measured by decreased
GSH production (Figs. 2A and S1C) and phosphate ester hydrolysis
(Figs. 2B and S1D) from purine ribonucleoside monophosphates,
ADP, and ADP-ribose. NaF did not inhibit GSH generation when
inosine [PNP substrate] [17], ribose5P [NOB-PPP substrate] [18], or
glucose6P [OB-PPP substrate] [18] were the carbon chain fuel
sources or the carbon chain fuel (Fig. 2A). These results show that
cytosolic acid phosphatases initiate catabolism of purine ribonu-
cleoside monophosphates (including AMP-5’ produced by adeny-
late kinase; Fig. 1, Reaction 1) and that cytosolic ADP-ribose pyr-
ophosphatase initiates catabolism of ADP-ribose. In contrast, in-
osine (a purine ribonucleoside), ribose5P, and glucose6P, when
added to cytosol, are catabolized spontaneously (Fig. 2A).
3.2. Pi requirement for the spontaneous extracellular catabolism of
purine ribonucleosides by PNP
The Pi released by 3′-5′ nucleotidase activity of extracellular
cytosolic acid phosphatases is co-substrate for PNP, which con-
verts inosine to ribose1P/hypoxanthine and guanosine to ribo-
se1P/guanine (Fig. 1, Reactions 2 and 4). Fig. 2A shows that added
inosine is spontaneously catabolized and is an effective carbon
chain fuel source. Maximal GSH production occurred even though
the reaction mixture Pi concentration was below the limit of de-
tection when the experiment was terminated (Fig. 2B). To decrease
the Pi available for the PNP reaction we lowered the reaction
mixture cytosolic protein concentration from 200 ng/μl (0.02%
solution of cytosolic protein) (Fig. 2) to 75 ng/μl (0.0075% solution
of cytosolic protein) (Fig. 3). This also lowered the reaction mix-
ture Pi concentration as determined by a need for supplemental Pi
for maximal GSH production (Fig. 3). To determine if co-substrate
Pi consumption is a marker of PNP catalytic activity, Pi was added
to reaction mixtures (except those labeled controls) in increasing
amounts (Fig. 3A–D). Experiments shown in Fig. 3A did not have
BPO
4
-3
µM
AD
P 2
mM
AM
P-5
' 2m
M
AM
P-3
' 2m
M
IMP
 2m
M
GM
P 2
mM
ino
sin
e 2m
M
ribo
se 5
P 2
mM
glu
cos
e 6P
 2m
M
AD
P-ri
bos
e 2m
M
0
1000
2000
3000
4000
5000
6000
Control NaF 1mM
A
G
SH
 µ
M
pH6.9   200 ng protein/µL pH6.9   200 ng protein/µL
0
1000
2000
3000
4000
5000
6000
AD
P 2
mM
AM
P-5
' 2m
M
AM
P-3
' 2m
M
IMP
 2m
M
GM
P 2
mM
ino
sin
e 2m
M
ribo
se 5
P 2
mM
glu
cos
e 6P
 2m
M
AD
P-ri
bos
e 2m
M
Control NaF 1mM
Fig. 2. Molecules with a structural ribose moiety and sugar phosphates are carbon chain fuel sources for NADPH production in dilute cytosol. (A) Effect of cytosolic acid
phosphatases and NaF on catabolism of carbon chain fuels or (B) phosphate ester hydrolysis in the same experiments as (A). NADPH generation was determined by
measurement of μM GSH produced from 3mM GSSG added to each experiment. X-axes show carbon chain fuel added to each experiment. X-axes (color coded bars) also
show experiments with and without NaF (A,B). Y-axes show μM GSH generated in experiments (A) or μM Pi produced by cytosolic acid phosphatases (B). 200 ng/μl cytosolic
protein and NADPþ 20 μM were added to all experiments. Incubations were for 1200 min at pH 6.9 at 37°. Data are the mean (7SEM) of three separately performed
experiments. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 3. Pi requirement for spontaneous extracellular catabolism of purine ribonucleosides. (A) Cytosol only without KH2PO4 (control) or cytosol only with added KH2PO4. (B–
D) Cytosol plus an added purine ribonucleoside and NADPþ without KH2PO4 (control) or with added KH2PO4. Presence of a purine ribonucleoside carbon chain fuel source
and NADPþ added to individual experiments are indicated above each panel (B–D). NADPH generation was determined by measurement of GSH produced from 3mM GSSG
added to all experiments (A–D). X-axes show control experiments (no Pi added) and experiments supplemented with Pi. Y-axes show on the left of panel μM GSH generated
and on the right of the panel μM Pi added or consumed (coded bars). 75 ng/μl cytosolic protein added to all experiments (A–D). Incubations were for 1200 min at pH 6.9 at
37°. Data are the mean (7SEM) of three separately performed experiments.
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baseline to compare Pi levels measured in metabolically active
reaction mixtures (Fig. 3B–D).Fig. 4. PAP and pH regulate extracellular catabolism of purine ribonucleoside monophosp
hydrolysis in the same experiments as (A). (C) GSH production without and with added
production without and with added PAP; pH 7.9. (F) Phosphate ester hydrolysis in the sa
produced from 3 mM GSSG added to each experiment. X-axes show the carbon chain fu
cytosol controls. X-axes (color coded bars) also show experiments with and without add
phosphatases or cytosolic acid phosphatases plus added PAP (B,D,F). 75 ng/μl cytosolic
1200 min at the pH indicated at 37°. Data are the mean (7SEM) of three separately p
legend, the reader is referred to the web version of this article.)We examined inosine, adenosine (co-substrate for PNP after
conversion to inosine by adenosine deaminase, Fig. 1 Reaction 3),
and guanosine (co-substrate for PNP) as carbon chain fuel sources.hates. (A) GSH productionwithout and with added PAP; pH 6.9. (B) Phosphate ester
PAP; pH 7.4. (D) Phosphate ester hydrolysis in the same experiments as (C). (E) GSH
me experiments as (E). NADPH generation was determined by measurement of GSH
el sources added to each experiment. A carbon chain fuel source was not added to
ed PAP. Y-axes show μM GSH generated (A,C,E) or μM Pi produced by cytosolic acid
protein and 20 μM NADPþ were added to all experiments. Incubations were for
erformed experiments. (For interpretation of the references to color in this ﬁgure
Fig. 5. GC–MS analysis of extracellular metabolite ﬂow from AMP-3’ and ribose5P correlated with GSH production. (A) AMP-3′ catabolism initiated by cytosolic acid
phosphatases. (B) Effect of added PAP on AMP-3′ catabolism. (C) Effect of not adding NADPþ on AMP-3′ catabolism. (D) Effect of not adding GSSG on AMP-3′ catabolism.
(E) Effect of pH 7.9 on AMP-3′ catabolism. (F) Effect of pH 8.2 on AMP-3′ catabolism. (G) Ribose5P catabolism at pH 6.7. (H) Ribose5P catabolism at pH 8.2. The added carbon
chain fuel sources were AMP-3′ 2 mM (A–F) and ribose5P 2 mM (G,H). All experiments contained NADPþ 20 μM except (C) and GSSG 3 mM except (D). PAP 1105 u/μl was
added to (B–F) but not to (A,G,H). Incubations were at 37°. X-axes show the time of termination for metabolite %AUC and GSH measurements. Note: time not to scale. Y-axes
show metabolite %AUC and μM GSH production. GSH production error bars from triplicate samples (mean7SEM) are marked in white. Most fall within the symbol denoting
the mean and are not visible.
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detect the presence of endogenous cytosolic Pi in control experi-
ments not supplemented with Pi (Fig. 3B–D), sufﬁcient en-
dogenous cytosolic Pi existed to support spontaneous catabolism
of purine ribonucleosides and the generation of 2 to 3 mM GSH. In
reaction mixtures supplemented with Pi, GSH production in-
creased compared to control experiments without supplemental
Pi. Maximal GSH production occurred with 250 μM KH2PO4 added
to reaction mixtures with purine ribonucleoside carbon chain fuel
sources (Fig. 3B–D). These results show that the extracellular Pi
concentration is rate limiting for the spontaneously occurring PNP
reaction, and that purine ribonucleoside induced Pi co-substrate
consumption is a marker of extracellular PNP catalytic activity.
3.3. Acid phosphatases and pH regulate extracellular metabolism of
purine ribonucleoside monophosphates
The initiation of extracellular catabolism by acid phosphatases
was further evaluated by lowering reaction mixture cytosolic
protein concentration to 75 ng/μl (Fig. 4). This reduced en-
dogenous cytosolic acid phosphatase activity for purine ribonu-
cleoside monophosphate carbon chain fuel sources, as measured
by GSH production and phosphate ester hydrolysis; compare en-
dogenous cytosolic acid phosphatase activity in experiments illu-
strated in Fig. 2A and B (200 ng/μl cytosolic protein) to the control
experiments (endogenous acid phosphatase activity only) in
Fig. 4A and B (75 ng/μl cytosolic protein). In addition we tested the
effect of pH and PAP on the initiation of purine ribonucleoside
monophosphate catabolism.
Added PAP increased GSH production and phosphate ester
hydrolysis at pH 6.9 and pH 7.4 (Fig. 4A–D). GSH production and
phosphate ester hydrolysis initiated by cytosolic acid phosphatases
with or without supplemental PAP was inhibited at pH 7.9 (Fig. 4E
and F). A higher concentration of PAP, 1104 u/μl, was added to
the experiments illustrated in Fig. 4E and F, but this did not reverse
the inhibition of GSH production (Fig. 4E). These results show that
added PAP supplements the activity of cytosolic acid phosphatases
and initiates maximal NADPH generating catabolism of purine ri-
bonucleoside monophosphates at pH 6.9 and pH 7.4. At pH 7.9 the
initiation of energy generating metabolism by cytosolic acid
phosphatases and by added PAP is totally inhibited, even when
phosphate ester hydrolysis occurs after adding 1104 u/μl PAP
(Fig.4E and F). This suggests that, in addition to acid phosphatase
inhibition, a second site of inhibition exists at pH 7.9.
3.4. Analysis of extracellular metabolic ﬂow
GC–MS was used to track metabolites during the catabolism of
AMP-3′ by the PNCP/PPP. Results are presented as %AUC of meta-
bolites measured (see Section 2). Triplicate reaction mixtures
containing 150 ng/μl cytosolic protein were sampled at 12 min,
120 min, 240 min, and 1200 min. GC–MS analysis and measure-
ment of GSH production was carried-out on each triplicate sample.
AMP-3′ catabolism, initiated by cytosolic acid phosphatases at pH
6.7 is shown in Fig. 5A. Signiﬁcant AMP-3′ remains uncatabolized
as determined by the slow decline of AMP-3′ %AUC and slow in-
crease in hypoxanthine %AUC (product of PNP; Fig. 1, Reaction 4)
during the 1200 min experiment. However, GSH production
(4.5 mM at 1200 min) occurs under conditions of low metabolite
ﬂow. To accelerate AMP-3′ catabolism, cytosolic acid phosphatases
were supplemented with PAP, 1105 u/μl at pH 6.9 (Fig. 5B).
Added PAP caused more rapid metabolite ﬂow as determined by
the following: rate of AMP-3′ %AUC decline, inosine and hypox-
anthine %AUC increase, appearance of adenosine %AUC, and in-
creased kinetics of GSH production compared to reaction mixtures
that were not supplemented with PAP (Fig. 5A vs. B). Theseexperiments show the importance of acid phosphatases in the
initiation of extracellular metabolite ﬂow that results in NADPH
production.
3.5. Effect of blocking reducing equivalent consumption on meta-
bolite proﬁles
To determine metabolite %AUC patterns when ﬂow of reducing
equivalents from the OB-PPP was blocked, the electron carrier
NADPþ or the electron acceptor GSSG were not added to reaction
mixtures (Fig. 5C and D). In both experiments, metabolites from
AMP-3′ ﬂowed through the PNCP and the NOB-PPP, but GSH was
not produced (Fig. 5C and D). However, in both cases glucose6P,
fructose6P (markers of terminal pathway malfunction), and se-
dohepulose7P began to accumulate between 12 min and 120 min
reaching a maximum during the 240 min to 1200 min interval.
This shows that terminal NOB-PPP metabolites accumulate at early
time points when the electron carrying cofactor NADPþ for the
OB-PPP is not present or when the electron acceptor GSSG was not
added to the reaction mixture. The similar metabolite proﬁle of
experiments illustrated in Fig. 5C and D reﬂect controlled redox
reactions with no evidence of indiscriminate reducing equivalent
ﬂow from the OB-PPP when either NADPþ or GSSG were not ad-
ded to reaction mixtures.
3.6. Effect of pH 7.9 and pH 8.2 on metabolic ﬂow
GC–MS results, when AMP-3′ catabolism is initiated at pH 7.9 in
the presence of 1105 u/μl of added PAP, are shown in Fig. 5E.
AMP-3′ hydrolysis occurs but metabolite ﬂow stops at transaldo-
lase (Fig. 1, Reaction 9) as determined by sedoheptulose7P accu-
mulation. Glucose6P and fructose6P are not detected and GSH
production is strongly inhibited. Initiation of AMP-3′ catabolism at
pH 8.2 in the presence of 1105 u/μl of added PAP is shown in
Fig. 5F. There is less AMP-3′ hydrolysis and metabolite ﬂow at pH
8.2 than observed at pH 7.9. This also is indicated by less inosine,
hypoxanthine, and sedoheptulose7P accumulation as determined
by %AUC; GSH production was strongly inhibited at pH 8.2. Results
presented in Fig. 3E and F show that alkaline pH inhibits: [1] acid
phosphatase initiation of metabolite ﬂow from AMP-3′ (pH 8.2)
and [2] metabolite ﬂow through the NOB-PPP enzyme transaldo-
lase, blocking sugar phosphate interconversion reactions that
synthesize glucose6P from sedoheptulose7P and glyceraldehyde3P
(pH 7.9 and pH 8.2).
To further evaluate metabolite ﬂow through transaldolase, ri-
bose5P (substrate for the NOB-PPP) was added to cytosol at pH 6.7.
This provides an immediate large substrate burden for cytosolic
NOB-PPP enzymes (Fig. 5G). At 120 min 3.7 mM GSH was gener-
ated and sedoheptulose7P %AUC appeared. By 240 min (GSH
4.7 mM) glucose6P plus fructose6P represented 50% of the meta-
bolite AUC and increased to 70% at 1200 min (GSH remained
4.7 mM) (Fig. 5G). Non-increase of GSH and marked accumulation
of glucose6P and fructose6P in this experiment reﬂects dysfunc-
tion of the OB-PPP, ineffective reducing equivalent delivery to
glutathione reductase, or impaired enzymatic activity of cytosolic
glutathione reductase. The same experiment was carried out at pH
8.2 (Fig. 5H). GSH production reached 2.0 mM at 240 min but was
diminished compared to the otherwise identical experiment car-
ried-out at pH 6.7 (Fig. 5G). Sedoheptulose7P %AUC appeared at
12 min, and increased progressively at 120 min, 240 min, and
1200 min, but fructose6P and glucose6P were not detected. This
conﬁrms that, at pH 8.2, ﬂow through transaldolase is inhibited
when the NOB-PPP is challenged with ribose5P.
Transaldolase is a phosphoprotein [19] that controls the di-
rection of metabolite ﬂow through the NOB-PPP [20]. It has ﬁve
phosphorylation sites [21] for the ubiquitous and constitutively
Fig. 6. Cytosolic adenylate kinase initiates ADP catabolism that produces NADPH for GSH production. Each experiment contained 200 ng/μl cytosolic protein, ADP 2mM,
GSSG 3mM, NADPþ 5 μM and 1105 u/μl PAP. Incubations were at 37°. (A) LC–MS analysis shows the fate of the ATP and AMP-5′ products of adenylate kinase. (B) GC–MS
analysis tracks further catabolism of the AMP-5′ product of the adenylate kinase reaction. X-axes show the time of termination for metabolite and GSH measurements. Note:
time not to scale. Y-axes show metabolite %AUC and μM GSH production. Fig. 5 legend describes GSH production.
Fig. 7. Effect on NADPH generation of dilution of cytosolic protein with autologous
serum protein dialyzed to remove glucose. X-axes (coded bars) show control ex-
periments (PAP not added) and experiments with added PAP. X-axes also show the
addition of NADPH or a carbon chain fuel source to experiments. Y-axes show μM
GSH generated from 3 mM GSSG. Asterisk marks added 20 μM NADPþ . Panel
(A) was identical to panel (B) except that 7470 ng/μl autologous dialyzed serum
protein was added to each experiment in panel B. Reaction mixtures contained
150 ng/μl cytosolic protein and were incubated for 1200 min at pH 6.9 at 37°. Data
represent the mean (7SEM) of 3 separately performed experiments. Cytosolic
protein and dialyzed serum were from the same donor.
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transaldolase with reagent acid phosphatase results in metabolite
ﬂow through the NOB-PPP in the direction of ribose5P to gluco-
se6P [19]. Phosphorylation of transaldolase blocks recycling of ri-
bose5P to glucose6P for oxidation by the OB-PPP [19]. The bio-
chemical phenotype observed in dilute cytosol at pH 7.9 or pH 8.2
(Fig. 5E, F, and H) is the same observed when transaldolase is
phosphorylated [19] or deﬁcient [23–25]. The ﬁndings reported in
Fig. 5E, F, and H suggest that, in dilute cytosol at alkaline pH,
transaldolase becomes phosphorylated by the ubiquitous and
constitutively active protein kinase CK2 [22].
3.7. Metabolite proﬁle of ADP catabolism
The proﬁle of ADP catabolismwas examined by LC–MS and GC–
MS (Fig. 6A and B) at pH 6.7 in triplicate reaction mixtures. LC–MS
showed that AMP-5′ and ATP are generated by cytosolic adenylate
kinase [26] (Fig. 1, Reaction 1) from ADP added to cytosol (Fig. 6A).
%AUC for ATP is maximal at 120 min and does not diminish during
the 1200 min experiment. %AUC of AMP-5′ decreases as GSH
production increases (Fig. 6A). Therefore, the action of cytosolic
adenylate kinase on ADP supplies AMP-5′ as a carbon chain fuel
source for NADPH generation and supplies the reaction mixture
with ATP which is not consumed in these experiments. GC–MS
metabolite proﬁle and kinetics of GSH production was similar to
that observed when AMP-3’ was the carbon chain fuel source
(compare Figs. 6B to 5A and B). A small amount of sedoheptulo-
se7P %AUC was measured at all-time points and glucose6P %AUC
was observed at the 1200 min. These results show that the action
of cytosolic adenylate kinase on ADP supplies the reaction mixture
with a carbon chain fuel source for NADPH generation (AMP-5′)
and a carrier of phosphoric acid anhydride bond energy (ATP).
3.8. Effect of dilution of cytosolic proteins with serum proteins on
GSH production
NADPH generation by cytosolic proteins diluted with a large
excess of dialyzed human serum proteins was evaluated. Experi-
ments with 150 ng/μl cytosolic proteins without added serum
proteins (Fig. 7A) were compared to identical experiments with
150 ng/μl cytosolic protein plus 7470 ng/μl of added human serum
proteins (Fig. 7B). Cytosolic proteins were 2% of total protein in the
experiments reported in Fig. 7B, but were still capable of gen-
erating undiminished NADPH from the catabolism of ribose5P,
glucose6P and, in the presence of added PAP, from purineribonucleoside monophosphates. Added reagent NADPH (3 mM)
was less effective than metabolically generated NADPH in deli-
vering reducing equivalents to glutathione reductase, as de-
termined by GSH production, in the presence of added serum
proteins (Fig. 7B). These experiments show the importance of
Fig. 8. Electron carrier requirement in dilute cytosol. Carbon chain fuel sources used in individual experiments are indicated above each panel. X-axes show control
experiments and experiments with added PAP (coded bars). X-axes also show the amount of NADPþ added to each experiment. Y-axes show μM GSH generated from 3 mM
GSSG. Reaction mixtures contained 191 ng/μl cytosolic protein and were incubated 1200 min at pH 6.9 at 37°. Data represent the mean (7SEM) of 3 separately performed
experiments.
Fig. 9. Effect of carbon chain fuel source concentration on GSH production by diluted cytosol prepared from lysates of human leukocytes. X-axes show control experiments
and experiments with added PAP (coded bars). X-axes also show carbon chain fuel source added to cytosolic protein in each experiment. Y-axes show μM GSH generated
from 3 mM added GSSG. The concentration of carbon chain fuel source added to experiments is indicated in the upper portion of each panel. Reaction mixtures contained
150 ng/μl cytosolic protein and were incubated for 1200 min at pH 6.9 at 37°. NADPþ 20 μM was added to all experiments. Data represent the mean (7SEM) of three
separately performed experiments.
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of extraneous serum proteins in extracellular metabolism carried
out in dilute cytosol.
3.9. Dose response with added NADPþ
We also determined the lowest concentration of NADPþ that
delivers metabolically produced reducing equivalents to glu-
tathione reductase, as measured by GSH production (Fig. 8A–C).
AMP-3′ with PAP and ribose5P without PAP support maximal GSH
production with 1 μM added NADPþ . AMP-5′ with PAP supports
maximal GSH production with 5 μM of added NADPþ . These re-
sults show that NADPþ is effectively cycled as a reducing
equivalent conduit between the OB-PPP and glutathione reductase
in metabolism carried out in dilute cytosol.
3.10. Dose response with added carbon chain fuel sources
Maximum GSH production from purine nucleoside monopho-
sphates, ribose-5P, and glucose-6P did not decline until the con-
centration of carbon chain fuels was lowered to 250 μM (Fig. 9A–
D). Endogenous cytosolic acid phosphatases produced maximum
GSSG reduction from 2 mM AMP-3′ and IMP. Other purine nu-
cleoside monophosphates required PAP for maximal GSH pro-
duction at 2 mM, 1 mM, and 500 μM carbon chain fuel source
concentrations (Fig. 9A–C). PAP increased GSH production from
250 μM purine nucleoside monophosphates but not to maximal
levels. Ribose5P and glucose6P maintained maximal GSH pro-
duction at 2 mM, 1 mM, and 500 μM but GSH production began to
decline when their concentrations were lowered to 250 μM
(Fig. 9D).
3.11. Kinetics of glucose6P and ribose5P metabolite ﬂow through the
PPP
Fig. 10 shows GSH production had linear kinetics between
30 min and 150 min when glucose6P, the carbon chain fuel for the
OB-PPP, was added at t¼0. At 150 min, 85% of added GSSG was
reduced to 2GSH. This redox poise remained constant until the
experiment was terminated at 240 min. Enzymes of the NOB-PPP
and the OB-PPP are both engaged in metabolism producing
NADPH for GSSG reduction when ribose5P is the carbon chain fuel
source (Fig. 1). Similar linear kinetics of GSH production were
observed between 30 min and 180 min when ribose5P was the
carbon chain fuel source added to dilute cytosol at t¼0 (Fig. 10). At
180 min, 88% of added GSSG was reduced to 2GSH and the redoxFig. 10. Comparison of glucose6P and ribose5P as carbon chain fuels by measuring
kinetics of GSH production. X-axis shows the time in minutes when GSH mea-
surements were performed. Y-axis shows μM GSH generated from 3 mM added
GSSG. Reaction mixtures contained 150 ng/μl cytosolic protein, 10 μM NADPþ and
were incubated at pH 6.9 at 37°. Data are the mean (7SEM) of three separately
performed experiments. Error bars are not visible and fall within the symbol de-
noting the mean.poise remained stable until the experiment was terminated. The
fact there is only a 30 min difference in maximum GSH production
shows efﬁcient function of the NOB-PPP in mediation of the sugar
phosphate interconversion reactions that synthesize glucose6P
from ribose5P.3.12. Kinetics of purine ribonucleoside monophosphate ﬂow through
the PNCP and PPP
We observed slower kinetics of metabolite ﬂow through the
PNCP and PPP with AMP-3’ as the carbon chain fuel source and a
reaction mixture cytosolic protein concentration of 150 ng/μl
(Fig. 5A and B). In contrast Fig. 10 shows rapid ﬂow through the
PPP of metabolites derived from ribose5P with the same cytosolic
protein concentration. Therefore, we increased the reaction mix-
ture cytosolic protein concentration to 202 ng/μl, with and with-
out 1105 u/μl PAP, to further evaluate the different kinetics of
PNCP and PPP metabolite ﬂow. AMP-3′ and IMP [acid phosphatase
and PNCP substrates] were compared to ribose5P [NOB-PPP sub-
strates], glucose6P [OB-PPP substrate] and reagent NADPH [co-
substrate for glutathione reductase] by measuring GSH production
at 240 min and 1200 min (Fig. 11). Results showed that GSH pro-
duction at 240 min was 3936 μM (66% GSSG reduction) for AMP-3′
and 3919 μM (65% GSSG reduction) for IMP. GSH production at
1200 min increased to 5445 μM (91% GSSG reduction) for AMP-3′
and 5394 μM (90% GSSG reduction) for IMP. In the same experi-
ments, maximum GSH production was achieved at 240 min for
ribose5P, glucose6P, and reagent NADPH. These results show a
more rapid kinetics for AMP-3′ metabolite ﬂow through the PNCP
at a cytosolic protein concentration of 202 ng/μl than at 150 ng/μl
cytosolic protein. However, these experiments conﬁrm that, under
conditions of our experiments, the kinetics of metabolite ﬂow
through the PPP is more rapid than through the PNCP.3.13. Pyrimidine ribonucleotides are not efﬁcient carbon chain fuel
sources
Table S1 compares a series of pyrimidine ribonucleoside
monophosphates and diphosphates to ADP and a series of purine
ribonucleoside monophosphates as carbon fuel chain sources for
the reduction of added GSSG. The results show that pyrimidine
ribonucleotides are not efﬁcient carbon chain fuel sources for ex-
tracellular NADPH production.Fig. 11. Comparative kinetics of purine ribonucleoside monophosphates and sugar
phosphates as carbon chain fuel sources for GSH production. X-axis shows control
experiments and experiments with added PAP (coded bars). X-axis also shows the
time of termination for GSH measurements and the carbon chain fuel source or
reagent NADPH added. Asterisk marks 10 μM added NADPþ . Y-axis shows μM GSH
generated from 3 mM GSSG. Reaction mixtures contained 202 ng/μl cytosolic pro-
tein and were incubated at pH 6.9 at 37°. Data are the mean (7SEM) of three
replicate experiments.
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The in vitro observations reported here must await results of
future in vivo experiments to determine their biological sig-
niﬁcance. However, extracellular metabolism that generates en-
ergy as NADPH from purine nucleotide carbon chain fuel sources
could have a role at sites of tissue injury and inﬂammation. The
enzymes responsible for extracellular metabolism were present in
reaction mixtures containing dilute cytosol (0.0075–0.02% protein)
prepared from lysates of human peripheral blood leukocytes.
These are cells that rapidly migrate into sites of tissue injury and
inﬂammation. Leukocyte lysis associated with cytosol preparation
is the experimental equivalent of cellular necrosis occurring in
perturbed tissue. In each case, the integrity of the plasma mem-
brane is lost and intracellular molecules are released into extra-
cellular space. Necrotic cell death, a response to stress by many
different cell types, causes inﬂammation [27]. Tissue perturbations
associated with necrosis, and release of intracellular molecules
into extracellular space, include microbial invasion, autoimmunity,
trauma, chemical toxicity, and ischemia–reperfusion. The de-
gradation of RNA released from necrotic cells produces AMP-3′/
AMP-5′ and GMP-3′/GMP-5′. Poly (ADP-ribose) polymerase acti-
vation in stressed cells precedes programmed necrosis and pro-
duces ADP-ribose polymers [6,27,28]. Platelet degranulation dur-
ing hemostasis releases ADP [3]. All are possible carbon chain fuel
sources for extracellular NADPH generation. Extravasation and
lysis of erythrocytes in perturbed tissue also could contribute to
extracellular NADPH generation by releasing glutathione, NADPþ ,
enzymes and ribose5P containing adenine nucleotides
[17,18,26,29]. Catalase is abundant in erythrocytes and is released
during lysis [30].
The extracellular NADPH producing metabolism described here
could moderate oxidative stress associated with tissue injury and
inﬂammation by regenerating GSH [5] and stabilizing catalase
[31]. This would lower extracellular H2O2 toward an optimum
concentration for tissue repair [32–34] and limit damage caused
by activated neutrophils, extracellular heme [29] and other pro-
oxidant factors.
In this study we used the NADPH dependent glutathione re-
ductase mediated reduction of GSSG to 2 GSH to quantitate
NADPH production. This shows that extracellular metabolism can
generate GSH for H2O2 removal by glutathione peroxidase. It is of
interest that efﬁcient enzymatic removal of H2O2 from perturbed
extracellular space either by the glutathione reductase/peroxidase
system or by catalase requires a source of extracellular NADPH
[5,31,35]. Each tetrameric catalase molecule binds four molecules
of NADPH. Bound NADPH protects catalase from inactivation by its
substrate H2O2 [31]. To maintain maximum catalase activity, a
supply of NADPH must be available to replace NADPþ as it is
formed [31,35]. A concentration of NADPH below 0.1 μM is sufﬁ-
cient to maintain catalase in its active form [31]. This suggests that
low levels of NADPH production could protect the enzymatic
function of catalase in extracellular space. Therefore, a source of
NADPH production is necessary for the enzymatic removal of H2O2
from perturbed intracellular or extracellular space.
Another site where extracellular metabolism generating
NADPH could occur is the female genital tract (FGT). PAP (Fig. 2C–
H) and necrosis can exist in the same proximity in the FGT. Neu-
trophils, 40–70% of blood leukocytes used for cytosol preparation,
migrate into the FGT as a response to insemination [36]. Sperma-
tozoa activate a unique type of programmed necrosis termed NET
formation [36,37]. NETs have antimicrobial activity and are a
precedent for continued function of macromolecules extruded
from necrotic neutrophils. Neutrophil death associated with NET
formation would release enzymes and ribose containing carbon
chain fuel sources needed for NADPH generation. The 1% (wt/vol)PAP content of seminal ﬂuid [38] (with no current known function
in the fertilization process) could facilitate extracellular energy
generating metabolism in the FGT. This could moderate fertiliza-
tion associated oxidative stress and increase spermatozoa survival.
Certain PPP enzymes have properties relevant to coordinated
metabolic function in extracellular space. For example, phos-
phoglucose isomerase (Fig. 1, Reaction 10) is a multifunctional
protein which acts extracellularly as autocrine motility factor and
is a marker for certain cancers [39]. Extracellular energy generat-
ing metabolism could complement the known extracellular cyto-
kine function of phosphoglucose isomerase by creating a redox
environment conducive to cell migration and angiogenesis needed
for wound healing or malignant cell spread [29,32–34,39,40]. It is
of interest that phophoglucose isomerase is phosphorylated by
protein kinase CK2 [39]. Like transaldolase [19], phosphorylation
of phosphoglucose isomerase by protein kinase CK2 inhibits its
enzymatic activity [39]. Also transaldolase, glucose-6-phosphate
dehydrogenase, and 6-phosphogluconate dehydrogenase form a
supramolecular complex in human neutrophils [41]. Supramole-
cular organization of PPP enzymes, if maintained after cell lysis
and cytosol preparation, would facilitate extracellular metabolism.
The experiments reported here could provide a model for in-
vestigation of supramolecular complex centered metabolism.
There are several examples from the literature relevant to the
in vitro extracellular metabolism we observed. The ﬁrst is the tu-
mor lysis syndrome (TLS) which is a complication of therapy in a
small subset of oncology patients [42]. Human tumors with a high
proliferation rate, a relatively large mass, and high sensitivity to
cytotoxic agents can respond to therapy with rapid cell lysis. This
results in extrusion of intracellular contents, including RNA and
purine ribonucleotides, into extracellular space. High blood levels
of uric acid are produced by extracellular catabolism of extruded
RNA and purine ribonucleotides. This is a major complication of
the TLS and is associated with renal impairment caused by uric
acid crystal nephropathy. The TLS is relevant because it provides
in vivo evidence in humans that the PNCP, when coupled to XOR,
carries out efﬁcient extracellular metabolism. XOR oxidizes hy-
poxanthine, a product of PNP (Fig. 1, Reactions 4) to xanthine and
then xanthine to uric acid (an antioxidant) [43]. The other pro-
ducts of XOR are either H2O2 or NADH.
The same PNCP enzymes that are active in extracellular space
in the TLS also function in dilute cytosol prepared from lysates of
human peripheral blood leukocytes in experiments reported here.
These in vitro studies show that the other PNP product, ribose1P,
becomes the carbon chain fuel source for extracellular NADPH
production by the PPP (Fig. 1 Reactions 5 and 6). The experiments
demonstrate that, like XOR, the PPP is coupled to the PNCP when
carrying out metabolic activity in extracellular space. The meta-
bolic bifurcation created by further metabolism of the PNP pro-
ducts, ribose1P and hypoxanthine, results in the production of an
array of redox active molecules that together can modulate the
redox environment of perturbed tissue either toward a more re-
duced or more oxidized redox poise. Proper functioning of this
purine ribonucleotide driven extracellular metabolism modulating
the redox environment could promote optimal repair of the per-
turbed tissue. Malfunction could interfere with tissue repair and
resolution of inﬂammation.
The second example relevant to the experiments reported here
is a recent study probing the evolutionary origin of core cellular
metabolism [44]. The purpose of the study was to provide em-
pirical evidence to support the theory of a prebiotic origin of
metabolism, e.g., the metabolism ﬁrst hypothesis [45]. The ex-
periments demonstrated that abiotic metabolic networks develop
under conditions designed to mimic the geochemical and tem-
perature environment of the ancient Archean ocean. Sugar phos-
phate interconversion reactions similar to those of the NOB-PPP
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metabolism was facilitated by metals such as ferrous iron that
acted as catalysts. The results we report here are similar to these
interesting experiments in so far as both involve the same com-
ponent of core metabolism found in all three domains of life [46]
and both produce, in dilute solution, the sugar phosphate inter-
mediates of the NOB-PPP.
In conclusion we show that, in dilute solutions of cytosolic
proteins prepared from lysates of human leukocytes, the ribose5P
moiety of purine nucleotides is a carbon chain fuel source for
NADPH production. The extracellular extraction of ribose5P from
purine nucleotides and its conversion to glucose6P requires the
combined coordinated action of acid phosphatases, the PNCP, and
the NOB-PPP. Glucose6P generated without energy input is then
oxidized by the OB-PPP to produce NADPH. The released in-
tracellular contents of necrotic cells and extravasated erythrocytes
that undergo lysis contain the purine ribonucleotide substrates
and enzymes that carry out this thermodynamically favorable
NADPH generating metabolism [17,18,26,29,30,35,41]. If this dilute
solution extracellular metabolism can be demonstrated in humans
it could modulate the redox environment of perturbed tissue and
inﬂuence the complex process of repair.Acknowledgments
We are grateful to R.D. Bloebaum and the Dept of Veterans
Affairs for support. We thank J.P. Kushner, D.L. Granger, J.B.
Weinberg, D.A. McClain and J.D. Phillips for critical reading and
insightful comments on the manuscript. Special thanks to D.L.
Granger for helpful discussions and to J.C. Peterson and F.A. Hibbs
for assistance with the manuscript. The authors report no conﬂict
of interest. Partial funding for this work was through NIH grant 1
P30 DK072437 (J. Cox, Co-I) and Dept. of Defense grant W81XWH-
06-01-0574 (R.D. Bloebaum, PI).Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.redox.2016.02.001.References
[1] M.A. Marletta, P.S. Yoon, R. Iyengar, C.D. Leaf, J.S. Wishnok, Macrophage oxi-
dation of L-arginine to nitrite and nitrate: Nitric oxide is and intermediate,
Biochemistry 27 (1988) 8706–8711, http://dx.doi.org/10.1021/bi00424a003.
[2] J.S. Clegg, Properties and metabolism of the aqueous cytoplasm and its
boundaries, Am. J. Physiol. 246 (1984) R133–R151.
[3] J.P. Greer, J. Foerster, G.M. Rodgers, F. Paraskevas, B. Glader, D.A. Arber, R.
T. Means Jr., Wintrobe’s Clinical Hematology, 12th edition, Lippincott Williams
and Wilkins, Philadelphia, PA, 2009.
[4] A.B. Fulton, How crowded is the cytoplasm? Cell 30 (1982) 345–347, http://dx.
doi.org/10.1016/0092-8674(82)90231-8.
[5] F.Q. Schafer, G.R. Buettner, Redox environment of the cell as viewed through
the redox state of the glutathione disulﬁde/glutathione couple, Free Rad. Biol.
Med. 30 (2001) 1191–1212, http://dx.doi.org/10.1016/S0891-5849(01)00480-4.
[6] S.A. Andrabi, N.S. Kim, S.W. Yu, H. Wang, D.W. Koh, M. Sasaki, J.A. Klaus,
T. Otsuka, Z. Zhang, R.C. Koehler, P.D. Hurn, G.G. Poirier, V.L. Dawson, T.
M. Dawson, Poly(ADP-ribose) (PAR) polymer is a death signal, Proc. Natl. Acad.
Sci. USA 103 (2006) 18308–18313, http://dx.doi.org/10.1073/pnas.0606526103.
[7] I. Ginis, K. Zaner, J.S. Wang, N. Pavlotsky, A.I. Tauber, Comparison of actin
changes and calcium metabolism in plastic-and ﬁbronectin-adherent human
neutrophils, J. Immunol. 149 (1992) 1388–1394.
[8] G.G. Tomazella, I. da Silva, H.J. Laure, J.C. Rosa, R. Chammas, H.G. Wilker, G.
A. de Souza, L.J. Greene, Proteomic analysis of total cellular proteins of human
neutrophils, Proteome Sci. 7 (2009) 32, http://dx.doi.org/10.1186/
1477-5956-7-32.
[9] S. Allen, J.M. Shea, T. Felmet, J. Gadra, P.F. Dehn, A kinetic microassay for
glutathione in cells plated on 96-well microtiter plates, Methods Cell Sci. 22
(2000) 305–312, http://dx.doi.org/10.1023/A:1017585308255.[10] B. Ames, Assay of inorganic phosphate, total phosphate and phosphatases,
Methods Enzymol. 8 (1966) 115–118.
[11] A. Jiye, J. Trygg, J. Gullberg, A.I. Johansson, P. Jonsson, H. Antti, S.L. Marklund,
T. Moritz, Extraction and GC/MS analysis of the human blood plasma meta-
bolome, Anal. Chem. 77 (2005) 8086–8094, http://dx.doi.org/10.1021/
ac051211v.
[12] D.K. Bricker, E.B. Taylor, J.C. Schell, T. Orsak, A. Boutron, Y.C. Chen, J.E. Cox, C.
M. Cardon, J.G. Van Vranken, N. Dephoure., C. Redin, S. Boudina, S.P. Gygi,
M. Brivet, C.S. Thummel, J.A. Rutter, Mitochondrial pyruvate carrier required
for pyruvate uptake in yeast, drosophila and humans, Science 337 (2012)
96–100, http://dx.doi.org/10.1126/science.1218099.
[13] O.L. Podhajcer, J.E. Filmus, J. Mordoh, Characterization of lysosomal acid
phosphatase from normal and malignant mammary tissue, Clin. Chem. 32
(1986) 279–282.
[14] P. Vihko, Characterization of the principal human prostatic acid phosphatase
isoenzyme, puriﬁed by afﬁnity chromatography and isoelectric focusing. Part
ll, Clin. Chem. 24 (1978) 1783–1787.
[15] J.M. Halleen, H. Kaija, J.J. Stepan, P. Vihko, H.K. Väänänen, Studies on the
protein tyrosine phosphatase activity of tartrate-resistant acid phosphatase,
Arch. Biochem. Biophys. 352 (1998) 97–102, http://dx.doi.org/10.1006/
abbi.1998.0600.
[16] S. Lin, L. Gasmi, Y. Xie, K. Ying, S. Gu, Z. Wang, H. Jin, Y. Chao, C. Wu, Z. Zhou,
R. Tang, Y. Mao, A.G. McLennan, Cloning, expression and characterization of a
human Nudix hydrolase speciﬁc for adenosine 5′-diphosphoribose (ADP-ri-
bose), Biochem. Biophys. Acta 1594 (2002) 127–135, http://dx.doi.org/10.1016/
S0167-4838(01)00296-5.
[17] S.Y. Chu, P. Cashion, M. Jiang, Purine nucleoside phosphorylase in erythrocytes:
determination of optimum reaction conditions, Clin. Biochem. 22 (1989) 3–9,
http://dx.doi.org/10.1016/S0009-9120(89)80062-1.
[18] F.J. Lionetti, Pentose phosphate pathway in human erythrocytes, in:
H. Yoshikawa, S.M. Rapaport (Eds.), Cellular and Molecular Biology of Ery-
throcytes, Univ. Park Press, Baltimore, 1974, pp. 143–166.
[19] F. Lachaise, G. Martin, C. Drougard, A. Perl, M. Vuillaume, M. Wegnez,
A. Sarasin, L. Daya-Grosjean, Relationship between posttranslational mod-
iﬁcation of transaldolase and catalase deﬁciency in uv-sensitive repair-deﬁ-
cient xeroderma pigmentosum ﬁbroblasts and SV40-transformed human cells,
Free Radic. Biol. Med. 30 (2001) 1365–1373, http://dx.doi.org/10.1016/
S0891-5849(01)00532-9.
[20] T. Wood, The forward and reverse reactions of transaldolase, FEBS Lett. 25
(1972) 153–155, http://dx.doi.org/10.1016/0014-5793(72)80474-5.
[21] K. Banki, D. Halladay, A. Perl, Cloning and expression of the human gene for
transaldolase. A novel highly repetitive element constitutes an integral part of
the coding sequence, J. Biol. Chem. 269 (1994) 2847–2851.
[22] F. Meggio, L.A. Pinna, One-thousand-and-one substrates of protein kinase
CK2? FASEB J. 17 (2003) 349–368, http://dx.doi.org/10.1096/fj.02-0473rev.
[23] N.M. Verhoeven, J.H.J. Huck, B. Roos, E.A. Struys, G.S. Salomons, A.C. Douwes,
M.S. van der Knaap, C. Jakobs, Transaldolase deﬁciency: liver cirrhosis asso-
ciated with a new inborn error in the pentose phosphate pathway, Am. J.
Hum. Genet. 68 (2001) 1086–1092, http://dx.doi.org/10.1086/320108.
[24] M.M. Wamelink, D.E. Smith, E.E. Jansen, N.M. Verhoeven, E.A. Struys, C. Jakobs,
Detection of transaldolase deﬁciency by quantiﬁcation of novel seven-carbon
chain carbohydrate biomarkers in urine, J. Inherit. Metab. Dis. 30 (2007)
735–742, http://dx.doi.org/10.1007/s10545-007-0590-2.
[25] R. Hanczko, D.R. Fernandez, E. Doherty, Y. Qian, G. Vas, B. Niland, T. Telarico,
A. Garba, S. Banerjee, F.A. Middleton, D. Barrett, M. Barcza, K. Banki, S.
K. Landas, A. Perl, Prevention of hepatocarcinogenesis and increased sus-
ceptibility to acetaminophen-induced liver failure in transaldolase-deﬁcient
mice by N-acetylcysteine, J. Clin. Investig. 119 (2009) 1546–1557, http://dx.doi.
org/10.1172/JCI35722.
[26] P. Cerletti, E. Bucci, Adenylate kinase of mammalian erythrocytes, Biochim.
Biophys. Acta 38 (1960) 45–56, http://dx.doi.org/10.1016/0006-3002(60)
91194-X.
[27] W.X. Zong, C.B. Thompson, Necrotic death as a cell fate, Genes Dev. 20 (2006)
1–15, http://dx.doi.org/10.1101/gad.1376506.
[28] J. Hitomi, D.E. Christofferson, A. Ng, J. Yao, A. Degterev, R.J. Xavier, J. Yuan,
Identiﬁcation of a molecular signaling network that regulates a cellular ne-
crotic cell death pathway by a genome wide siRNA screen, Cell 135 (2008)
1311–1323, http://dx.doi.org/10.1016/j.cell.2008.10.044.
[29] F.A.D.T.G. Wagener, H.E. van Beurden, J.W. von den Hoff, G.J. Adema, C.
G. Figdor, The heme-heme oxygenase system: a molecular switch in wound
healing, Blood 102 (2003) 521–528, http://dx.doi.org/10.1182/
blood-2002-07-2248.
[30] N.S. Agar, S. Sadrzadeh, H. M., P.E. Hallaway, J.W. Eaton, Erythocyte catalase: A
somatic oxidant defense? J. Clin. Investig. 77 (1986) 319–321, http://dx.doi.
org/10.1172/JCI112294.
[31] H.N. Kirkman, S. Galiano, G.F. Gaetani, The function of catalase-bound NADPH,
J. Biol. Chem. 262 (1987) 660–666.
[32] S. Roy, S. Khanna, K. Nallu, T.K. Hunt, C.K. Sen, Dermal wound healing is
subject to redox control, Mol. Ther. 13 (2006) 211–220, http://dx.doi.org/
10.1016/j.ymthe.2005.07.684.
[33] M. Schäfer, S. Werner, Oxidative stress in normal and impaired wound repair,
Pharmcol. Res. 58 (2008) 165–171, http://dx.doi.org/10.1016/j.
phrs.2008.06.004.
[34] S.S. Huang, R.L. Zheng, Biphasic regulation of angiogenesis by reactive oxygen
species, Pharmazie 61 (2006) 223–229.
[35] M.D. Scott, T.C. Wagner, D.T. Chiu, Decreased catalase activity is the underlying
J.B. Hibbs Jr. et al. / Redox Biology 8 (2016) 271–284284mechanism of oxidant susceptibility in glucose-6-phosphate dehydrogenase
deﬁcient erythrocytes, Biochim. Biophys. Acta 1181 (2) (1993) 163–168, http:
//dx.doi.org/10.1016/0925-4439(93)90106-B.
[36] A.S. Alghamdi, D.N. Foster, Seminal DNase frees spermatozoa entangled in
neutrophil extracellular traps, Biol. Reprod. 73 (2005) 1174–1181, http://dx.
doi.org/10.1095/biolreprod.105.045666.
[37] T.A. Fuchs, U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn,
Y. Weinrauch, V. Brinkmann, A. Zychlinsky, Novel cell death program leads to
neutrophil extracellular traps, J. Cell Biol. 176 (2007) 231–241, http://dx.doi.
org/10.1083/jcb.200606027.
[38] l Rönnberg, P. Vihko, E. Sajanti, R. Vihko, Clomiphene citrate administration to
normogonadotropic subfertile men: Blood hormone changes and activation of
acid phosphatase in seminal ﬂuid, Int. J. Androl. 4 (1981) 372–378, http://dx.
doi.org/10.1111/j.1365-2605.1981.tb00721.x.
[39] T. Yangawa, T. Funasaka, S. Tsutsumi, T. Raz, N. Tanaka, A. Raz, Differential
regulation of phosphoglucose isomerase/autocrine motility factor activities by
protein kinase CK2 phosphorylation, J. Biol. Chem. 280 (2005) 10419–10426,
http://dx.doi.org/10.1074/jbc.M409457200.
[40] L.S. Terada, Speciﬁcity in reactive oxidant signaling: Think globally, act locally,J. Cell Biol. 174 (2006) 615–623, http://dx.doi.org/10.1083/jcb.200605036.
[41] J.B. Huang, J. Espinoza, R. Romero, H.R. Petty, Transaldolase is part of a su-
pramolecular complex containing glucose-6-phosphate dehydrogenase in
human neutrophils that undergoes retrograde trafﬁcking during pregnancy,
Metabol. Clin. Exp. 54 (2005) 1027–1033, http://dx.doi.org/10.1016/j.
metabol.2005.03.005.
[42] F.P. Wilson, J.S. Berns, Onco-nephrology: Tumor lysis syndrome, Clin. J. Am.
Soc. Nephrol. 7 (2012) 1730–1739, http://dx.doi.org/10.2215/CJN.03150312.
[43] R. Harrison, Structure and function of xanthine oxidoreductase: Where are we
now? Free Rad. Biol. Med. 33 (2002) 774–797, http://dx.doi.org/10.1016/
S0891-5849(02)00956-5.
[44] M.A. Keller, A.V. Turchyn, M. Ralser, Non-enzymatic glycolysis and pentose
phosphate pathway-like reactions in a plausible Archean ocean, Mol. Syst.
Biol. 10 (2014) 725, http://dx.doi.org/10.1002/msb.20145228.
[45] P.L. Luisi, Prebiotic metabolic networks? Mol. Syst. Biol. 10 (2014) 729, http:
//dx.doi.org/10.1002/msb.20145351.
[46] H. Jeong, B. Tombor, R. Albert, Z.N. Oltval, A.L. Barabasi, The large-scale or-
ganization of metabolic networks, Nature 407 (2000) 651–654, http://dx.doi.
org/10.1038/35036627.
